EUVIMEDEUVIMED entdecken
Crossref

Structure-Activity Relationship Studies on Potential Non-Nucleoside DABO-Like Inhibitors of HIV-1 Reverse Transcriptase

R Costi, R Di Santo, M Artico, S Massa, A Lavecchia, T Marceddu, L Sanna, P La Colla, M E Marongiu

Antiviral Chemistry and Chemotherapy · 2000

DOI: 10.1177/095632020001100204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antiviral Chemistry and Chemotherapy, 2000. Verfasst von R Costi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Pasteur Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Università di Roma La Sapienza, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using 2,6-dichloro-4-aminopyrimidine, a number of uracil and cytosine derivatives with both arylthio and alkoxy moieties were prepared. These novel pyrimidines share chemical similarities with DABOs and HEPTs, two classes of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors (NNRTIs), which have been widely studied of late. All new derivatives were tested in MT-4 cells to explore their potential in vivo anti-HIV activity. Like other NNRTIs, they selectively inhibit HIV-1 but not HIV- 2. The majority of test derivatives were found to have low potency and were sometimes more cytotoxic than zidovudine and emivirine (formerly MKC-442), used here as reference drugs. Uracil and cytosine derivatives bearing a sec-butoxy chain and a methyl-substituted benzenesulphonyl moiety were the most potent. Enzyme assays proved that these derivatives target RT. Structure-activity relationship studies established a correlation between the anti-HIV-1 activity and the meta substitution on the phenyl ring; furthermore, oxidation of sulphide to sulphone significantly increased the potency of certain derivatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Evaluation, PreclinicalHumansMicrobial Sensitivity TestsNucleosidesPyrimidinonesReverse Transcriptase InhibitorsStructure-Activity RelationshipSulfides

Substanzen

5-isopropyl-2-((methylthiomethyl)thio)-6-(benzyl)pyrimidin-4(1H)-oneNucleosidesPyrimidinonesReverse Transcriptase InhibitorsSulfides

Autor:innen und Institutionen

  • Istituto Pasteur Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Università di Roma La Sapienza, Italy.

Zitieren

APA

Costi, R., Di Santo, R., Artico, M., Massa, S., Lavecchia, A., Marceddu, T., Sanna, L., La Colla, P., & Marongiu, M. E. (2000). Structure-Activity Relationship Studies on Potential Non-Nucleoside DABO-Like Inhibitors of HIV-1 Reverse Transcriptase. Antiviral Chemistry and Chemotherapy. https://doi.org/10.1177/095632020001100204

Vancouver

Costi R, Di Santo R, Artico M, Massa S, Lavecchia A, Marceddu T, et al. Structure-Activity Relationship Studies on Potential Non-Nucleoside DABO-Like Inhibitors of HIV-1 Reverse Transcriptase. Antiviral Chemistry and Chemotherapy. 2000. doi:10.1177/095632020001100204

BibTeX
@article{Costi2000,
  author = {Costi, R and Di Santo, R and Artico, M and Massa, S and Lavecchia, A and Marceddu, T and Sanna, L and La Colla, P and Marongiu, M E},
  title = {Structure-Activity Relationship Studies on Potential Non-Nucleoside DABO-Like Inhibitors of HIV-1 Reverse Transcriptase},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2000},
  doi = {10.1177/095632020001100204}
}
Kostenlos starten →